Pharmaceutical Microbiology
- Microbial Identification – bacteria, yeasts, and filamentous fungi
° MALDI-TOF Mass Spectrometry (Bruker MALDI Biotyper®) - Antimicrobial/Preservative Effectiveness
- USP <51>
- ISO 11930:2012
- Personal Care Products Council (PCPC) Methods – M-3, M-6, and M-7
- Stability Studies
- LAL Endotoxin Analysis, USP <85> (Kinetic Chromogenic Assay )
- USP <61> Microbial Enumeration Tests
- USP <62> Tests for Specified Organisms
- Clostridia
- Gram Negative
- Salmonella
- Escherichia coli
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Candida albicans
- Burkholderia cepacia complex (BCC) <60>
- USP Suitability Assays
- USP <1227> Validation of Microbial Recovery
- USP <2021> & <2022> Microbiology for Dietary Supplements
- FDA-Bacteriological Analytical Manual (BAM) – Chapter 23 – Microbiological Methods for Cosmetics
- Minimum Inhibitory Concentration (MIC) Evaluations
- Minimum Bactericidal Concentration (MBC) Evaluations
- Time-Kill Studies
Environmental Monitoring
- Cleaning Validation
- RODAC Plating
- Air Density Analysis
- Swab / Sponge Testing
- Total Plate Count
- Water Quality Monitoring
- Yeast and Mold Count and Identification
